Back to Journals » OncoTargets and Therapy » Volume 16
Original Research
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
3,456 | Dovepress* | 3,146+ | 69 | 3,215 | |
PubMed Central* | 310 | 57 | 367 | ||
Totals | 3,456 | 126 | 3,582 | ||
*Since 1 April 2023 |
View citations on PubMed Central and Google Scholar